Title: Changhung Chen: Innovator in Complement Factor B Analogs
Introduction
Changhung Chen is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of complement factor B analogs. His work focuses on innovative solutions that can potentially impact various medical conditions.
Latest Patents
Changhung Chen holds a patent titled "Complement Factor B Analogs And Their Uses." This invention provides polypeptides comprising a complement factor B analog. The invention also includes various complement factor B analogs that feature a mutation of a free cysteine amino acid, along with related methods, nucleic acids, and vectors. These complement factor B analogs and their associated methods can be utilized to modulate a complement pathway or for the study and treatment of various conditions or diseases related to this pathway. Notably, he currently has 0 patents.
Career Highlights
Changhung Chen is associated with Pharma Cinq, LLC, where he continues to advance his research and development efforts. His work is pivotal in exploring the therapeutic applications of complement factor B analogs.
Collaborations
Some of his notable coworkers include Michael Kaleko and Beibei Li. Their collaborative efforts contribute to the innovative research being conducted at Pharma Cinq, LLC.
Conclusion
Changhung Chen's work in the field of complement factor B analogs showcases his commitment to advancing biotechnology. His innovative approaches have the potential to lead to significant breakthroughs in medical treatments.